J, P., N, D., X, L., X, H., W, Z., H, X., . . . Z, X. (2025). Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials. Annals of surgical oncology, 32(2), 750. https://doi.org/10.1245/s10434-024-16454-8
Chicago Style (17th ed.) CitationJ, Pang, et al. "Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials." Annals of Surgical Oncology 32, no. 2 (2025): 750. https://doi.org/10.1245/s10434-024-16454-8.
MLA (9th ed.) CitationJ, Pang, et al. "Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials." Annals of Surgical Oncology, vol. 32, no. 2, 2025, p. 750, https://doi.org/10.1245/s10434-024-16454-8.